HCA
HALO icon

Harbor Capital Advisors’s Halozyme HALO Stock Holding History

Harbor Capital Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89M Buy
36,977
+5,622
+18% +$383K 0.2% 134
2026
Q1 		$2.03M Buy
+31,355
New +$2.21M 0.16% 182
2025
Q3 		– Sell
-309
Closed -$16K – 1402
2025
Q2 		$16K Sell
309
-27
-8% -$1.54K ﹤0.01% 835
2025
Q1 		$21K Buy
336
+92
+38% +$5.34K ﹤0.01% 798
2024
Q4 		$12K Buy
244
+13
+6% +$667 ﹤0.01% 912
2024
Q3 		$13K Buy
+231
New +$13.2K ﹤0.01% 896

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Harbor Capital Advisors's HALO Position: Q2 2026 in Review

Harbor Capital Advisors increased its Halozyme (HALO) stake by 18% in Q2 2026, buying an estimated $383K and bringing the position to 36,977 shares worth $2.89M. The position accounts for 0.2% of the portfolio, ranked #134.

Harbor Capital Advisors first reported a position in HALO in Q3 2024 and has held it in 6 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Harbor Capital Advisors held 36,977 shares of Halozyme worth $2.89M as of Q2 2026.
  • Harbor Capital Advisors bought 5,622 Halozyme shares in Q2 2026, an estimated $383K.
  • Halozyme made up 0.2% of Harbor Capital Advisors's portfolio in Q2 2026, its #134 holding.
  • Harbor Capital Advisors first reported a position in Halozyme in Q3 2024 and has held it in 6 quarters since.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Harbor Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.